as of now there is Institutional Support for yesbank!!
SMBC, SBI, Advent, Carlyle providing stability
Strong Financial Recovery
Q4 FY25 net profit surged 63%, to ₹738 crore, beating expectations. This was driven by a 32.5% drop in provisioning and a steady GNPA of 1.6%. Net interest income rose 5.7%, while fee and other income grew 11%.
Full-year net profit nearly doubled (+92.3%), bringing FY25’s net profit to ₹2,406 crore. Total income, NII, and cost-to-income ratio all improved.
Q1 FY26 results show further momentum:
Net profit jumped 59% YoY to ₹801 crore.
NIM rose to 2.5%.
Non‑interest income ratio soared from 39% to 58.7%.
Assets and deposits expanded.
Strategic Capital & Institutional Backing
SMBC (Sumitomo Mitsui Banking Corporation) has invested as much as 20%, with regulatory approval for up to 24.99%, offering global expertise, stronger governance, and future capital injections.
Major institutional shareholders like SBI, Advent, and Carlyle reinforce investorconfidence.
SMBC, SBI, Advent, Carlyle providing stability
Strong Financial Recovery
Q4 FY25 net profit surged 63%, to ₹738 crore, beating expectations. This was driven by a 32.5% drop in provisioning and a steady GNPA of 1.6%. Net interest income rose 5.7%, while fee and other income grew 11%.
Full-year net profit nearly doubled (+92.3%), bringing FY25’s net profit to ₹2,406 crore. Total income, NII, and cost-to-income ratio all improved.
Q1 FY26 results show further momentum:
Net profit jumped 59% YoY to ₹801 crore.
NIM rose to 2.5%.
Non‑interest income ratio soared from 39% to 58.7%.
Assets and deposits expanded.
Strategic Capital & Institutional Backing
SMBC (Sumitomo Mitsui Banking Corporation) has invested as much as 20%, with regulatory approval for up to 24.99%, offering global expertise, stronger governance, and future capital injections.
Major institutional shareholders like SBI, Advent, and Carlyle reinforce investorconfidence.
עסקה פעילה
i entered @20.5
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.